Prostate Cancer Clinical Trials

Find Prostate Cancer Clinical Trials Near You

The Effect of Inflammatory Bowel Disease Flares on Serum Prostate Specific Antigen

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This study will measure Prostate Specific Antigen (PSA) values in men with Inflammatory Bowel Disease (IBD) before, during, and following a flare. In addition, the effect of any PSA increase will be analyzed and correlated to the location of disease (rectal vs. other). Study findings may help men with IBD by identifying pitfalls in prostate cancer screening for this population and help to stratify and understand the effect IBD has on the prostatic milieu. By optimizing how men with IBD are screened for prostate cancer, future unnecessary healthcare encounters and expenditures may be reduced for this patient group.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 40
Maximum Age: 69
Healthy Volunteers: f
View:

• Men, ages 40-69 years old

• Confirmed diagnosis of IBD presenting to the Northwestern Memorial Hospital Gastroenterology Clinic

Locations
United States
Illinois
Northwestern Medicine
RECRUITING
Chicago
Contact Information
Primary
Shilajit Kundu, MD
shilajit.kundu@nm.org
312-695-8146
Backup
Jazmine Stockdale, MS
urology@northwestern.edu
312-694-2417
Time Frame
Start Date: 2019-08-01
Estimated Completion Date: 2025-10-01
Participants
Target number of participants: 400
Treatments
Men with Inflammatory Bowel Disease
Men with a confirmed diagnosis of IBD between the ages of 40-69 years old. These subjects will have their prostate specific antigen checked via a blood draw during clinic visits over the course of the study period.
Related Therapeutic Areas
Sponsors
Leads: Northwestern University

This content was sourced from clinicaltrials.gov